Purpose: The most prevalent intervention for localized prostate cancer (pca) is radical prostatectomy (rp), which has a 10-year relative survival rate of more than 90%. The improved survival rate has led to a focus on reducing the burden of treatment-related morbidity and improving the patient and partner survivorship experience. Post-rp sexual dysfunction (sdf) has received significant attention, given its substantial effect on patient and partner health-related quality of life. Accordingly, there is a need for sdf treatment to be a fundamental component of pca survivorship programming. Methods: Most research about the treatment of post-rp sdf involves biomedical interventions for erectile dysfunction (ed). Although findings support the effectiveness of pro-erectile agents and devices, most patients discontinue use of such aids within 1 year after their rp. Because side effects of pro-erectile treatment have proved to be inadequate in explaining the gap between efficacy and ongoing use, current research focuses on a biopsychosocial perspective of ed. Unfortunately, there is a dearth of literature describing the components of a biopsychosocial program designed for the post-rp population and their partners. Results: In this paper, we detail the development of the Prostate Cancer Rehabilitation Clinic (pcrc), which emphasizes multidisciplinary intervention teams, active participation by the partner, and a broad-spectrum medical, psychological, and interpersonal approach. Conclusions: The goal of the pcrc is to help patients and their partners achieve optimal sexual health and couple intimacy after rp, and to help design cost-effective and beneficial rehabilitation programs.
Purpose: The most prevalent intervention for localized prostate cancer (pca) is radical prostatectomy (rp), which has a 10-year relative survival rate of more than 90%. The improved survival rate has led to a focus on reducing the burden of treatment-related morbidity and improving the patient and partner survivorship experience. Post-rp sexual dysfunction (sdf) has received significant attention, given its substantial effect on patient and partner health-related quality of life. Accordingly, there is a need for sdf treatment to be a fundamental component of pca survivorship programming. Methods: Most research about the treatment of post-rp sdf involves biomedical interventions for erectile dysfunction (ed). Although findings support the effectiveness of pro-erectile agents and devices, most patients discontinue use of such aids within 1 year after their rp. Because side effects of pro-erectile treatment have proved to be inadequate in explaining the gap between efficacy and ongoing use, current research focuses on a biopsychosocial perspective of ed. Unfortunately, there is a dearth of literature describing the components of a biopsychosocial program designed for the post-rp population and their partners. Results: In this paper, we detail the development of the Prostate Cancer Rehabilitation Clinic (pcrc), which emphasizes multidisciplinary intervention teams, active participation by the partner, and a broad-spectrum medical, psychological, and interpersonal approach. Conclusions: The goal of the pcrc is to help patients and their partners achieve optimal sexual health and couple intimacy after rp, and to help design cost-effective and beneficial rehabilitation programs.
Entities:
Keywords:
Prostate cancer; biospsychosocial approaches; rehabilitation; sexual dysfunction
Authors: Andrea Salonia; Arthur L Burnett; Markus Graefen; Kostas Hatzimouratidis; Francesco Montorsi; John P Mulhall; Christian Stief Journal: Eur Urol Date: 2012-05-03 Impact factor: 20.096
Authors: Adele Duimering; Lauren M Walker; Jill Turner; Elisha Andrews-Lepine; Amy Driga; Ashley Ayume; John W Robinson; Ericka Wiebe Journal: Support Care Cancer Date: 2019-08-19 Impact factor: 3.603
Authors: Quynh Pham; Jason Hearn; Jacqueline L Bender; Alejando Berlin; Ian Brown; Denise Bryant-Lukosius; Andrew H Feifer; Antonio Finelli; Geoffrey Gotto; Robert Hamilton; Ricardo Rendon; Joseph A Cafazzo Journal: BMJ Open Date: 2021-04-21 Impact factor: 2.692
Authors: A G Matthew; L J Trachtenberg; Z G Yang; J Robinson; A Petrella; D McLeod; L Walker; R Wassersug; S Elliott; J Ellis; L Jamnicky; N Fleshner; A Finelli; R Singal; G Brock; K Jarvi; J Bender; D Elterman Journal: Support Care Cancer Date: 2021-08-31 Impact factor: 3.603
Authors: Quynh Pham; Jason Hearn; Bruce Gao; Ian Brown; Robert J Hamilton; Alejandro Berlin; Joseph A Cafazzo; Andrew Feifer Journal: NPJ Digit Med Date: 2020-09-02